Incretin-based agents in type 2 diabetic patients at cardiovascular risk: compare the effect of GLP-1 agonists and DPP-4 inhibitors on cardiovascular and pancreatic outcomes
Crossref DOI link: https://doi.org/10.1186/s12933-017-0512-z
Published Online: 2017-03-01
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhang, Zeqing
Chen, Xi
Lu, Puhan
Zhang, Jianhua
Xu, Yongping
He, Wentao
Li, Mengni
Zhang, Shujun
Jia, Jing
Shao, Shiying
Xie, Junhui
Yang, Yan
Yu, Xuefeng
Funding for this research was provided by:
National Nature Science Foundation of China (81570740)